Prevention of preeclampsia with antioxidants: Evidence from randomized trials

Clinical Obstetrics and Gynecology

Volumn 48, Issue 2, 2005, Pages 416-429

  Spinnato, Joseph A ^a   Livingston, Jeffery C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CAROTENOID; LIPID PEROXIDE; LYCOPENE; MAGNESIUM SULFATE; MELATONIN; NICOTINE; REACTIVE OXYGEN METABOLITE; SELENIUM; UBIQUINONE; ZINC;

ANTIOXIDANT ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HUMAN; LIPID PEROXIDATION; META ANALYSIS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PUBLIC HEALTH; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR DISEASE; REVIEW; SYSTEMATIC REVIEW; VASCULAR ENDOTHELIUM; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDATION; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS;

EID: 18044363454     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000160312.74983.f3     Document Type: Review

References (86)

1. Walker JJ. Antioxidants and inflammatory cell response in preeclampsia. Semin Reprod Endocrinol. 1998;16:47-55.
2. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222-235.
3. Walsh S. Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia. Semin Reprod Endocrincol. 1998;16:93-104.
4. Saeed SA, Mitchell MD. Conversion of arachidonic acid to lipoxygenase products by human fetal tissues. Biochem Med. 1983;30:322-327.
5. Thakur S, Gupta N, Kakkar P. Serum copper and zinc concentrations and their relation to superoxide dismutase in severe malnutrition. Eur J Pediatr. 2004; (e-pub prior to publication).
6. Barua RS, Ambrose JA, Srivastava S, et al. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107:2342-2347.
7. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94:1112-1117.
8. Teran E, Racines-Orbe M, Vivero S, et al. Preeclampsia is associated with a decrease in plasma coenzyme Q10 levels. Free Radic Biol Med. 2003;35:1453-1456.
9. Milczarek R, Klimek J, Zelewski L. Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria. Horm Metab Res. 2000;32:84-85.
10. Nakamura Y, Tamura H, Kashida S, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30:29-33.
11. Okatani Y, Wakatsuki A, Shinohara K, et al. Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res. 2001;30:199-205.
12. Okatani Y, Wakatsuki A, Shinohara K, et al. Melatonin protects against oxidative mitochondrial damage induced in rat placenta by ischemia and reperfusion. J Pineal Res. 2001;31:173-178.
13. Arikan S, Konukoglu D, Arikan C, et al. Lipid peroxidation and antioxidant status in maternal and cord blood. Gynecol Obstet Invest. 2001;51:145-149.
14. Takehara Y, Yoshioka T, Sasaki J. Changes in the levels of lipoperoxide and antioxidant factors in human placenta during gestation. Acta Med Okayama. 1990;44:103-111.
15. Burlingame JM, Esfandiari N, Sharma RK, et al. Total antioxidant capacity and reactive oxygen species in amniotic fluid. Obstet Gynecol. 2003;101:756-761.
16. De Vriese SR, Dhont M, Christophe AB. Oxidative stability of low density lipoproteins and vitamin E levels increase in maternal blood during normal pregnancy. Lipids. 2001;36:361-366.
17. Arikan S, Konukoglu D, Arikan C, et al. Lipid peroxidation and antioxidant status in maternal and cord blood. Gynecol Obstet Invest. 2001;51:145-149.
18. Mihailovic M, Cvetkovic M, Ljubic A, et al. Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biol Trace Elem Res. 2000;73:47-54.
19. Morris JM, Gopaul NK, Endresen MJ, et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol. 1998;105:1195-1199.
20. Rayman MP, Abou-Shakra FR, Ward NI, et al. Comparison of selenium levels in pre-eclamptic and normal pregnancies. Biol Trace Elem Res. 1996;55:9-20.
21. Zachara BA, Wardak C, Didkowski W, et al. Changes in blood selenium and glutathione concentrations and glutathione peroxidase activity in human pregnancy. Gynecol Obstet Invest. 1993;35:12-17.
22. Gratacos E, Casals E, Deulofeu R, et al. Serum and placental lipid peroxides in chronic hypertension during pregnancy with and without superimposed preeclampsia. Hypertens Pregnancy. 1999;18:139-146.
23. Yanik FF, Amanvermez R, Yanik A, et al. Pre-eclampsia associated with increased lipid peroxidation and decreased serum vitamin E levels. Int J Gynaecol Obstet. 1999;64:27-33.
24. Poranen AK, Ekblad U, Uotila P, et al. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta. 1996;17:401-405.
25. Uotila JT, Tuimala RJ, Aarnio TM, et al. Findings on lipid peroxidation and antioxidant function in hypertensive complications of pregnancy. Br J Obstet Gynaecol. 1993;100:270-276.
26. Kharb S, Gulati N, Singh V, et al. Lipid peroxidation and vitamin E levels in pre-eclampsia. Gynecol Obstet Invest. 1998;46:238-240.
27. Akyol D, Mungan T, Gorkemli H, et al. Maternal levels of vitamin E in normal and preeclamptic pregnancy. Arch Gynecol Obstet. 2000;263:151-155.
28. Kharb S. Vitamin E and C in preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2000;93:37-39.
29. Kharb S. Lipid peroxidation in pregnancy with preeclampsia and diabetes. Gynecol Obstet Invest. 2000;50:113-116.
30. Wang Y, Walsh SW. Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas. J Soc Gynecol Investig. 1996;3:179-184.
31. Mikhail MS, Anyaegbunam A, Garfinkel D, et al. Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia. Am J Obstet Gynecol. 1994;171:150-157.
32. Hubel CA, Kagan VE, Kisin ER, et al. Increased ascorbate radical formation and ascorbate depletion in plasma from women with preeclampsia: implications for oxidative stress. Free Radic Biol Med. 1997;23:597-609.
33. Rayman MP, Abou-Shakra FR, Ward NI, et al. Comparison of selenium levels in pre-eclamptic and normal pregnancies. Biol Trace Elem Res. 1996;55:9-20.
34. Mutlu-Turkoglu U, Ademoglu E, Ibrahimoglu L, et al. Imbalance between lipid peroxidation and antioxidant status in preeclampsia. Gynecol Obstet Invest. 1998;46:37-40.
35. Shaarawy M, Aref A, Salem ME, et al. Radical-scavenging antioxidants in pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 1998;60:123-128.
36. Harma M, Harma M, Erel O. Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly. 2003;133:563-566.
37. Williams MA, Woelk GB, King IB, et al. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens. 2003;16:665-672.
38. Aksoy H, Taysi S, Altinkaynak K, et al. Antioxidant potential and transferrin, cerulo-plasmin, and lipid peroxidation levels in women with preeclampsia. J Investig Med. 2003;51:284-287.
39. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys. 1991;288:481-487.
40. Bisseling TM, Maria Roes E, Raijmakers MT, et al. N-acetylcysteine restores nitric oxide-mediated effects in the fetoplacental circulation of preeclamptic patients. Am J Obstet Gynecol. 2004;191:328-333.
41. Madazli R, Benian A, Aydin S, et al. The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia. Obstet Gynaecol. 2002;22:477-480.
42. Orhan H, Onderoglu L, Yucel A, et al. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet. 2003;267:189-195 [e-pub October 15, 2002].
43. Serdar Z, Gur E, Colakoethullary M, et al. Lipid and protein oxidation and antioxidant function in women with mild and severe pre-eclampsia. Arch Gynecol Obstet. 2003;268:19-25.
44. Ilhan N, Simsek M. The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia. Clin Biochem. 2002;35:393-397.
45. Kumru S, Aydin S, Simsek M, et al. Comparison of serum copper, zinc, calcium, and magnesium levels in preeclamptic and healthy pregnant women. Biol Trace Elem Res. 2003;94:105-112.
46. Lazebnik N, Kuhnert BR, Kuhnert PM. Zinc, cadmium, and hypertension in parturient women. Am J Obstet Gynecol. 1989;161:437-440.
47. Mahomed K, Williams MA, Woelk GB, et al. Leukocyte selenium, zinc, and copper concentrations in preeclamptic and normotensive pregnant women. Biol Trace Elem Res. 2000;75:107-118.
48. Vaughn JS, Walsh SW. Oxidative stress reproduces placental abnormalities of pre-eclampsia. Hypertens Pregnancy. 2002;21:205-223.
49. Madazli R, Aydin S, Uludag S, et al. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand. 2003;82:797-802.
50. Anim-Nyame N, Gamble J, Sooranna SR, et al. Microvascular permeability is related to circulating levels of tumour necrosis factor-alpha in pre-eclampsia. Cardiovasc Res. 2003;58:162-169.
51. Scalera F. Intracellular glutathione and lipid peroxide availability and the secretion of vasoactive substances by human umbilical vein endothelial cells after incubation with TNF-alpha. Eur J Clin Invest. 2003;33:176-182.
52. Visser W, Beckmann I, Knook MA, et al. Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Scand. 2002;81:713-719.
53. Munno I, Chiechi LM, Lacedra G, et al. Spontaneous and induced release of prostaglandins, interleukin (IL)-1beta, IL-6, and tumor necrosis factor-alpha by placental tissue from normal and preeclamptic pregnancies. Am J Reprod Immunol. 1999;42:369-374.
54. Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, et al. Expression of the placental cytokines tumor necrosis factor alpha, interleukin 1beta, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol. 1999;181:915-920.
55. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol. 1996;32:157-169.
56. Vince GS, Starkey PM, Austgulen R, et al. Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol. 1995;102:20-25.
57. Greer IA, Lyall F, Perera T, et al. Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction? Obstet Gynecol. 1994;84:937-940.
58. Agarwal R, Campbell RC, Warnock DG. Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Semin Nephrol. 2004;24:101-114.
59. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep. 2002;4:160-166.
60. Leung PS, Tsai SJ, Wallukat G, et al. The upregulation of angiotensin II receptor AT(1) in human preeclamptic placenta. Mol Cell Endocrinol. 2001;184:95-102.
61. Ozan H, Ilcol Y, Kimya Y, et al. Plasma anti-oxidant status and lipid profile in non-gravida women with a history of preeclampsia. J Obstet Gynaecol Res. 2002;28:274-279.
62. Pressman EK, Cavanaugh JL, Mingione M, et al. Effects of maternal antioxidant supplementation on maternal and fetal antioxidant levels: a randomized, double-blind study. Am J Obstet Gynecol. 2003;189:1720-1725.
63. Chappell LC, Seed PT, Briley AL, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999;354:810-816.
64. Chappell LC, Seed PT, Kelly FJ, et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187:777-784.
65. Beazley D, Ahokas R, Livingston J, et al. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo-controlled trial. Am J Obstet Gynecol. 2005;192:520-521.
66. Stratta P, Canavese C, Porcu M, et al. Vitamin E supplementation in preeclampsia. Gynecol Obstet Invest. 1994;37:246-249.
67. Gulmezoglu AM, Hofmeyr GJ, Oosthuisen MM. Antioxidants in the treatment of severe pre-eclampsia: an explanatory randomised controlled trial. Br J Obstet Gynaecol. 1997;104:689-696.
68. Yamini S, West KP Jr, Wu L, et al. Circulating levels of retinol, tocopherol and carotenoid in Nepali pregnant and postpartum women following long-term beta-carotene and vitamin A supplementation. Eur J Clin Nutr. 2001;55:252-259.
69. Williams MA, Woelk GB, King IB, et al. Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women. Am J Hypertens. 2003;16:665-672.
70. Palan PR, Mikhail MS, Romney SL. Placental and serum levels of carotenoids in preeclampsia. Obstet Gynecol. 2001;98:459-462.
71. Zhang C, Williams MA, Sanchez SE, et al. Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women. Am J Epidemiol. 2001;153:572-580.
72. Sharma JB, Kumar A, Malhotra M, et al. Effect of lycopene on pre-eclampsia and intra-uterine growth retardation in primigravidas. Int J Gynaecol Obstet. 2003;81:257-262.
73. Mahomed K, Williams MA, Woelk GB, et al. Leukocyte selenium, zinc, and copper concentrations in preeclamptic and normotensive pregnant women. Biol Trace Elem Res. 2000;75:107-118.
74. Jonsson B, Hauge B, Larsen MF, et al. Zinc supplementation during pregnancy: a double blind randomised controlled trial. Acta Obstet Gynecol Scand. 1996;75:725-729.
75. Rayman MP, Bode P, Redman CW. Low selenium status is associated with the occurrence of the pregnancy disease preeclampsia in women from the United Kingdom. Am J Obstet Gynecol. 2003;189:1343-1349.
76. Han L, Zhou SM. Selenium supplement in the prevention of pregnancy induced hypertension. Chin Med J (Engl). 1994;107:870-871.
77. Duley L, Gulmezoglu AM, Henderson-Smart DJ. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2003:CD000025.
78. Sibai BM, Villar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989;161:115-119.
79. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988;95:120-125.
80. Barua RS, Ambrose JA, Srivastava S, et al. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107:2342-2347.
81. Conde-Agudelo A, Althabe F, Belizan JM, et al. Cigarette smoking during pregnancy and risk of preeclampsia: a systematic review. Am J Obstet Gynecol. 1999;181:1026-1035.
82. Burke BE, Neuenschwander R, Olson RD. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J. 2001;94:1112-1117.
83. Milczarek R, Klimek J, Zelewski L. Melatonin inhibits NADPH-dependent lipid peroxidation in human placental mitochondria. Horm Metab Res. 2000;32:84-85.
84. Nakamura Y, Tamura H, Kashida S, et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res. 2001;30:29-33.
85. Okatani Y, Wakatsuki A, Shinohara K, et al. Melatonin stimulates glutathione peroxidase activity in human chorion. J Pineal Res. 2001;30:199-205.
86. Okatani Y, Wakatsuki A, Shinohara K, et al. Melatonin protects against oxidative mitochondrial damage induced in rat placenta by ischemia and reperfusion. J Pineal Res. 2001;31:173-178.